Zhujiang Hospital: Ischemic Stroke trials
The registry lists 11 Ischemic Stroke studies with Zhujiang Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 1Phase 3 1No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Ischemic StrokeNot yet recruitingNCT07232563Phase 1
- A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic StrokeRecruitingNCT06712004Phase 2
- Interleukin-6 Receptor Inhibition for Symptomatic Intracranial AtherosclerosisNot yet recruitingNCT06447701Phase 3
- The Correlation of Intracranial Artery Calcification and Outcomes of Mechanical ThrombectomyRecruitingNCT06418698
- Screening of New Markers of Gut Microbiota in Stroke and Depression: a Cross-sectional StudyRecruitingNCT06379464
- Dynamic Changes in Human Microbiome Predict the Risk of Adverse Outcomes in Patients With Acute Ischemic Stroke: a Multicenter Prospective Cohort StudyRecruitingNCT06240468
- Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic StrokeStatus unknownNCT05850208Phase 1
- The Correlation Between CITED2 and Collateral Circulation in Acute Ischemic StrokeCompletedNCT05345366
- Relationships Among FVIII, t-PA/PAI-1, and MMP-9 Levels and Intracranial Hemorrhage Complications After Thrombolysis With Alteplase in Patients With Acute Ischemic Stroke: Protocol for a Multicenter Retrospective StudyStatus unknownNCT03733223
- The Antidepressant Effects of rTMS After Ischemic StrokeStatus unknownNCT03159351Not applicable
- The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-plateletWithdrawnNCT02677818